Mesenchymal stem cells attenuate adriamycin‐induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF‐kB
Authors:
- 25 April 2018
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 23 (5) , 483-492
Abstract
Aim: This study aimed to evaluate the molecular mechanism mitigating progress of chronic nephropathy by mesenchymal stem cells (MSCs).Methods: Rats were divided into normal control (Normal), adriamycin (ADR)+vehicle (CON), and ADR+MSC (MSC) groups. Nephropathy was induced by ADR (4 mg/kg) and MSCs (2 × 106) were injected. Rats were euthanized 1 or 6 weeks after ADR injection. NF‐kB, MAPKs, inflammation, oxidative stress, profibrotic molecules, and nephrin expression were evaluated. Electron and light microscopy were used for structural analysis. MSCs were co‐cultured with renal tubular epithelial cells or splenocytes to evaluate relation with oxidative stress and inflammatory moleculesResults: Adriamycin treatment upregulated inflammation, oxidative stress, and profibrotic molecules; this was mitigated by MSCs. Glomerulosclerosis and interstitial fibrosis were observed in ADR‐treated groups, and were more prominent in the CON group than in the MSC group. Fusion of foot processes and loss of slit diaphragms were also more prominent in the CON group than in the MSC group. In vitro, MSCs reduced oxidative stress related molecules, inflammatory cytokines, and NF‐kB transcription. MSC‐ or ADR‐induced regulation of NF‐kB transcriptional activity was confirmed by a luciferase reporter assay.Conclusions: Mesenchymal stem cells attenuate ADR‐induced nephropathy by diminishing oxidative stress and inflammation via downregulation of NF‐kB.Keywords
This publication has 25 references indexed in Scilit:
- An Overview of Molecular Mechanism of Nephrotic SyndromeInternational Journal of Nephrology, 2012
- MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathyBiological Research, 2012
- Chronic kidney disease growth factors in renal fibrosisClinical and Experimental Pharmacology and Physiology, 2011
- Adriamycin nephropathy: A model of focal segmental glomerulosclerosisNephrology, 2010
- Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life spanThe FASEB Journal, 2009
- Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytesKidney International, 2009
- Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected ratsNephrology Dialysis Transplantation, 2008
- Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosisAmerican Journal of Physiology-Renal Physiology, 2008
- By Homing to the Kidney, Activated Macrophages Potently Exacerbate Renal InjuryThe American Journal of Pathology, 2008
- Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosisCancer Letters, 1996